276 related articles for article (PubMed ID: 24498325)
1. Bone marrow-specific knock-in of a non-activatable Ikkα kinase mutant influences haematopoiesis but not atherosclerosis in Apoe-deficient mice.
Tilstam PV; Gijbels MJ; Habbeddine M; Cudejko C; Asare Y; Theelen W; Zhou B; Döring Y; Drechsler M; Pawig L; Simsekyilmaz S; Koenen RR; de Winther MP; Lawrence T; Bernhagen J; Zernecke A; Weber C; Noels H
PLoS One; 2014; 9(2):e87452. PubMed ID: 24498325
[TBL] [Abstract][Full Text] [Related]
2. Non-activatable mutant of inhibitor of kappa B kinase α (IKKα) exerts vascular site-specific effects on atherosclerosis in Apoe-deficient mice.
Tilstam PV; Soppert J; Hemmers C; Harlacher E; Döring Y; van der Vorst EPC; Schulte C; Alampour-Rajabi S; Theelen W; Asare Y; de Winther MPJ; Lawrence T; Bernhagen J; Schober A; Zernecke A; Jankowski J; Weber C; Noels H
Atherosclerosis; 2020 Jan; 292():23-30. PubMed ID: 31733453
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency.
Wang M; Subramanian M; Abramowicz S; Murphy AJ; Gonen A; Witztum J; Welch C; Tabas I; Westerterp M; Tall AR
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):976-84. PubMed ID: 24651678
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
[TBL] [Abstract][Full Text] [Related]
5. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
[TBL] [Abstract][Full Text] [Related]
6. Grb2 is required for atherosclerotic lesion formation.
Proctor BM; Ren J; Chen Z; Schneider JG; Coleman T; Lupu TS; Semenkovich CF; Muslin AJ
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1361-7. PubMed ID: 17363695
[TBL] [Abstract][Full Text] [Related]
7. Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis.
Schmitz C; Noels H; El Bounkari O; Straussfeld E; Megens RTA; Sternkopf M; Alampour-Rajabi S; Krammer C; Tilstam PV; Gerdes N; Bürger C; Kapurniotu A; Bucala R; Jankowski J; Weber C; Bernhagen J
FASEB J; 2018 Aug; 32(8):4428-4443. PubMed ID: 29543531
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.
Du F; Yu F; Wang Y; Hui Y; Carnevale K; Fu M; Lu H; Fan D
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):759-67. PubMed ID: 24504735
[TBL] [Abstract][Full Text] [Related]
9. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
10. Sirt6 deletion in bone marrow-derived cells increases atherosclerosis - Central role of macrophage scavenger receptor 1.
Arsiwala T; Pahla J; van Tits LJ; Bisceglie L; Gaul DS; Costantino S; Miranda MX; Nussbaum K; Stivala S; Blyszczuk P; Weber J; Tailleux A; Stein S; Paneni F; Beer JH; Greter M; Becher B; Mostoslavsky R; Eriksson U; Staels B; Auwerx J; Hottiger MO; Lüscher TF; Matter CM
J Mol Cell Cardiol; 2020 Feb; 139():24-32. PubMed ID: 31972266
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis.
Van Eck M; Herijgers N; Yates J; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3117-26. PubMed ID: 9409301
[TBL] [Abstract][Full Text] [Related]
12. Protection of atherogenesis in thromboxane A2 receptor-deficient mice is not associated with thromboxane A2 receptor in bone marrow-derived cells.
Zhuge X; Arai H; Xu Y; Murayama T; Kobayashi T; Narumiya S; Kita T; Yokode M
Biochem Biophys Res Commun; 2006 Dec; 351(4):865-71. PubMed ID: 17097058
[TBL] [Abstract][Full Text] [Related]
13. FoxO4 inhibits atherosclerosis through its function in bone marrow derived cells.
Zhu M; Zhang QJ; Wang L; Li H; Liu ZP
Atherosclerosis; 2011 Dec; 219(2):492-8. PubMed ID: 22005198
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
[TBL] [Abstract][Full Text] [Related]
15. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
[TBL] [Abstract][Full Text] [Related]
16. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis.
Borst O; Schaub M; Walker B; Schmid E; Münzer P; Voelkl J; Alesutan I; Rodríguez JM; Vogel S; Schoenberger T; Metzger K; Rath D; Umbach A; Kuhl D; Müller II; Seizer P; Geisler T; Gawaz M; Lang F
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):547-57. PubMed ID: 25614279
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell PECAM-1 promotes atherosclerotic lesions in areas of disturbed flow in ApoE-deficient mice.
Harry BL; Sanders JM; Feaver RE; Lansey M; Deem TL; Zarbock A; Bruce AC; Pryor AW; Gelfand BD; Blackman BR; Schwartz MA; Ley K
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2003-8. PubMed ID: 18688018
[TBL] [Abstract][Full Text] [Related]
18. AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction.
Huang Q; Qin L; Dai S; Zhang H; Pasula S; Zhou H; Chen H; Min W
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):795-804. PubMed ID: 23413429
[TBL] [Abstract][Full Text] [Related]
19. Genetic deletion of chemokine receptor Ccr7 exacerbates atherogenesis in ApoE-deficient mice.
Wan W; Lionakis MS; Liu Q; Roffê E; Murphy PM
Cardiovasc Res; 2013 Mar; 97(3):580-8. PubMed ID: 23180724
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow- or vessel wall-derived osteoprotegerin is sufficient to reduce atherosclerotic lesion size and vascular calcification.
Callegari A; Coons ML; Ricks JL; Yang HL; Gross TS; Huber P; Rosenfeld ME; Scatena M
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2491-500. PubMed ID: 23990207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
